Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, leading to
death within an average of 2–3 years. A cure is yet to be found, and a single disease …

It is now well recognized that, in addition to motor impairment, amyotrophic lateral sclerosis
(ALS) may cause extra-motor clinical signs and symptoms. These can include the alteration …

Background Amyotrophic lateral sclerosis (ALS) people have a high risk of severe mental
disorders, like depression, which impacts their function, quality of life, and mobility. However …

Previously thought to be a pure motor disease, amyotrophic lateral sclerosis (ALS) is now
established as multisystem neurodegenerative disorder that lies on a continuum with …

Sleep disorders in amyotrophic lateral sclerosis (ALS) present a significant challenge to the
management of patients. Issues include the maintenance of adequate ventilatory status …

Amyotrophic lateral sclerosis (ALS) is a chronic progressive neurodegenerative disease.
Neurologists generally see patients as requested and as schedules allow. This practice is …

Objective: To report an observational study of depression in a large cohort of patients with
amyotrophic lateral sclerosis (ALS), including its prevalence, associations, longitudinal …

Objective The aims of this study were to (i) explore psychotic experiences across the entire
amyotrophic lateral sclerosis‐frontotemporal dementia (ALS‐FTD) spectrum from a clinical …

Overlap between motor neuron disease (MND) and frontotemporal dementia (FTD) occurs at
clinical, genetic and pathological levels, and has been recently strengthened through the …

The classic description of amyotrophic lateral sclerosis (ALS) has little to do with the
presence of neuropsychological dysfunction, and instead focuses largely on the motor …